News Bad week for dementia R&D after Axovant howler and another f... Axovant misreports trial results, Lundbeck Alzheimer's drug fails
News Lundbeck trial investigates genetic causes of depression New study with 23andMe and Milken Institute looks to determine causes of depression.
News Lundbeck enlists IBM Watson to aid psychiatric drug research Collaboration will initially focus on Parkinson's disease and schizophrenia.
News Lundbeck epilepsy injection approved in US New carbamazepine formulation when oral dosing not feasible.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
